Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03918408 · ClinicalTrials.gov registry record · Phase 1
Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking
A Phase 1 study of Keratoconus, Unstable and Bacterial Keratitis, sponsored by Pacific Clear Vision Institute.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT03918408 is a Phase 1 study of Keratoconus, Unstable and Bacterial Keratitis that is actively recruiting participants, run by Pacific Clear Vision Institute. The registered enrollment target is 300 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03918408, a Phase 1 study of Keratoconus, Unstable and Bacterial Keratitis, is actively recruiting participants, sponsored by Pacific Clear Vision Institute.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine whether the Peschke PXL-330 system is safe and effective in the treatment of corneal thinning conditions.
Conditions Studied
Interventions
- COMBINATION_PRODUCT PXL-330 Platinum device for crosslinking with Peschke ribofflavin solution
Study Locations (1)
Oregon
- Pacific Clear Vision Institute - Eugene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2030-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03918408
The ClinicalTrials.gov registry entry for NCT03918408 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pacific Clear Vision Institute, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Keratoconus, Unstable appearing as the primary indexed condition, and to 1 intervention - of which PXL-330 Platinum device for crosslinking with Peschke ribofflavin solution is the first listed.
NCT03918408 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT03918408 about?
NCT03918408 is a clinical study titled "Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking". To determine whether the Peschke PXL-330 system is safe and effective in the treatment of corneal thinning conditions.
What is the current status of trial NCT03918408?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 300 participants. The study started on 2019-09-01. Estimated completion is 2030-12.
What conditions does trial NCT03918408 study?
This clinical trial studies the following conditions: Keratoconus, Unstable, Bacterial Keratitis, Ectasia of Cornea.
What interventions are being tested in trial NCT03918408?
The interventions under investigation include: PXL-330 Platinum device for crosslinking with Peschke ribofflavin solution (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT03918408?
This trial is sponsored by Pacific Clear Vision Institute, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03918408 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Keratoconus, Unstable
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.